Latest News for: haematological
Edit
Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2 in Patients with Advanced Solid Tumors or Haematological Malignancies (Form 6-K) (Cytomed Therapeutics Ltd)
Public Technologies 21 Jul 2025
Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2 in Patients with Advanced Solid Tumors or Haematological Malignancies.
Edit
Our body’s crimson tide: the evolving treatment landscape in haematology
The Hindu 15 Jun 2025
The future of blood disorder treatment combines traditional medical knowledge with cutting-edge technology to provide better patient care ....
- 1